Search results
Tasuku Honjo (本庶 佑, Honjo Tasuku, born January 27, 1942) is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1).
The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation"
Tasuku Honjo. The Nobel Prize in Physiology or Medicine 2018. Born: 27 January 1942, Kyoto, Japan. Affiliation at the time of the award: Kyoto University, Kyoto, Japan. Prize motivation: “for their discovery of cancer therapy by inhibition of negative immune regulation”. Prize share: 1/2.
May 9, 2024 · Tasuku Honjo, Japanese immunologist who contributed to the discovery of mechanisms and proteins critical to the regulation of immune responses and whose work led to the development of novel immunotherapies against cancer. Honjo received a share of the 2018 Nobel Prize for Physiology or Medicine.
Oct 1, 2018 · Press release. 2018-10-01. The Nobel Assembly at Karolinska Institutet. has today decided to award. the 2018 Nobel Prize in Physiology or Medicine. jointly to. James P. Allison and Tasuku Honjo. for their discovery of cancer therapy by inhibition of negative immune regulation.
Oct 1, 2018 · James Allison at the University of Texas MD Anderson Cancer Center in Houston and Tasuku Honjo at Kyoto University in Japan will share the 9 million Swedish kronor (US$1 million) prize. The...
Born in Kyoto in 1942, Tasuku Honjo completed his medical degree at Kyoto University in 1966, and continued to study medical chemistry with Osamu Hayaishi, one of the pioneers in biochemistry and enzymology who had worked with Arthur Kornberg, and Yasutomi Nishizuka, one of Hayaishi’s former students at Kyoto University.
Related searches
